SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-004770
Filing Date
2020-02-26
Accepted
2020-02-26 06:05:40
Documents
9
Period of Report
2020-02-26

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea119027-6k_immuron.htm 6-K 19634
2 HALF YEARLY REPORT AND ACCOUNTS ea119027ex99-1_immuron.htm EX-99.1 514513
3 GRAPHIC ex99-1_001.jpg GRAPHIC 351796
4 GRAPHIC ex99-1_002.jpg GRAPHIC 293425
5 GRAPHIC ex99-1_003.jpg GRAPHIC 9495
6 GRAPHIC ex99-1_004.jpg GRAPHIC 297224
7 GRAPHIC ex99-1_005.jpg GRAPHIC 14630
8 GRAPHIC ex99-1_006.jpg GRAPHIC 319577
9 GRAPHIC ex99-1_007.jpg GRAPHIC 265733
  Complete submission text file 0001213900-20-004770.txt   2673686
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 20653223
SIC: 2834 Pharmaceutical Preparations